Mind Body Intervention for Long COVID-19 (NCT06045338) | Clinical Trial Compass
RecruitingNot Applicable
Mind Body Intervention for Long COVID-19
United States180 participantsStarted 2023-11-09
Plain-language summary
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adult (≥ 18 years of age)
✓. Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
✓. Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
✓. A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
✓. Symptoms present at least 3 day a week for a minimum of 3 months
✓. Willingness to engage in a Mind-Body intervention
Exclusion criteria
✕. Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
✕. Hospitalization in an intensive care unit for acute COVID-19 infections
✕. Age greater than 65 years
✕. Diagnosis of dementia or similar cognitive impairment